BPC 157 No Proof Required! Office for Science and Society McGill University Everyone's talking about peptides like this so let's actually look at the science. Yes there is a study on BPC 157 and cancer. But it's a 2004 conference abstract (not even a Injectable vs Oral BPC Busting the Myth BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Peptide BPC 157(HEXADECAPEPTIDE) Synthagen Synthagen PL